Eli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
8 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 8 separate news trends connected to Eli, spanning July 23, 2026 through October 29, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 52 article observations and 49 source signals, led by Business, Sports coverage. Use it to compare how individual events emerged, spread and changed over time.
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Missouri Attorney General sends cease-and-desist letter to Eli Lilly over drug pricing policy.
Epic teams up with Amazon Pharmacy, Eli Lilly, and Mark Cuban to launch a prescription drug pricing tool.
4 news sources are covering this Sports story right now — Archynetys is tracking how fast it spreads.
6 news sources are covering this Sports story right now — Archynetys is tracking how fast it spreads.
700,000 seniors start GLP-1 treatments under Medicare, with 70% on Eli Lilly drugs
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Eli Lilly's retatrutide shows promising results in weight loss trials, driving stock gains and regulatory anticipation